San Francisco, CA (PRWEB) January 22, 2016
Paper submission: Sensitive Sensors Pave the Way for Isolated Detection of Medical Conditions Through Molecular and Frequency Indicators
Paper submission: Medical Virtual Reality Treatments Provide Technological Solutions to Debilitating Conditions
Team members of Sensory Acumen received the Roy L. Clay Sr., Technology Pinnacle Award for the paper submissions of "Sensitive Sensors Pave the Way for Isolated Detection of Medical Conditions Through Molecular and Frequency Indicators" and "Medical Virtual Reality Treatments Provide Technological Solutions to Debilitating Conditions" during the Innovation & Equity 16: 50 Most Important African-Americans in Technology event on Martin Luther King's birthday on January 15, 2016, at the African American Art & Culture Complex in San Francisco. Roy L. Clay Sr. is a 2003 Silicon Valley Engineering Hall of Fame member who initiated the 50 Most Important African-Americans in Technology in 1999.
The paper, "Sensitive Sensors Pave the Way for Isolated Detection of Medical Conditions Through Molecular and Frequency Indicators," was presented by Charlene Coleman, Ralph L. Peterson, MD, Carl Childers and Michael Coleman, and covered research in diabetic ketoacidosis, nanotechnology, field-effect transistor (FET) and technological advances in sensors. “Diabetic ketoacidosis, in pediatric and adult cases, is caused by a deficiency of the hormone insulin and can attribute to cerebral edema. It is a cause of mortality and severe morbidity in children with diabetes; therefore, technologies like the sensor Sensory Acumen has developed is critical to early detection of the keytone acetone,” said Dr. Peterson, medical director of MacArthur GI.
Paper Abstract: There are life threatening conditions that currently are detected using blood and/or urine tests, or visual indicators. Conditions like untreated high blood glucose with positive ketones can lead to a life-threatening condition called diabetic ketoacidosis (DKA). Keytones are made up of certain molecules, and molecules have their own frequency. This paper will touch on research to detect conditions outside of the normal tests and/or animal sensitivity to certain conditions and how the development of wearable technology can assist with detection.
The paper, "Medical Virtual Reality Treatments Provide Technological Solutions to Debilitating Conditions," was presented by Charlene Coleman, Carl Childers and Michael Coleman, and covered psychotherapy and medical research, and technological advances in virtual reality.
Paper Abstract: Medical and psychological conditions have, for the most part, been treated with pharmaceuticals, natural herbal substances, cognitive therapy, exposure therapy, eye movement desensitization and reprocessing, or service animals. Current research is underway to determine how virtual reality can affect conditions such as post traumatic stress disorder (PTSD), stroke, Alzheimer’s, and traumatic brain injury (TBI). In this paper, you will learn how medical treatment research coupled with virtual reality technology can be applied to induce conscious memory recall (exposure therapy) and, in some cases, desensitization for foreseeable recurring experiences.
The event, Innovation & Equity 16: 50 Most Important African-Americans in Technology (http://souloftechnology.com/), was produced by Roy L. Clay Sr. (http://www.rodl.com/management.html) and John William Templeton of Zenviba Economic Development Corp. (http://www.zenviba.com/johnwilliamtempleton.html). “It was our pleasure to honor Roy L. Clay Sr. and deliver our papers at the scientific proceedings, as well as being selected as three of the 50 Most Important African-Americans in Technology, which raises the profiles of cutting-edge pioneers,” said Charlene Childers-Coleman, founder of Sensory Acumen.
About Sensory Acumen
Sensory Acumen is a company engaged in the development and deployment of technologies that will enhance the consumer experience in emerging areas like virtual reality, connected automobile, and personal sensors.